Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients

Clinical trial NCT01782651 · COMPLETED

Trial details

NCT number: NCT01782651
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Neoplasms, Breast

Start date: 2014-08-01
Primary completion: 2015-07-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.